Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART coh... by Walker, A, Ford, D, Gilks, C, Munderi, P, Ssali, F, Reid, A, Katabira, E, Grosskurth, H, Mugyenyi, P, Hakim, J, Darbyshire, J, Gibb, D, Babiker, A

“…FUNDING: UK Medical Research Council, the UK Department for International Development, the Rockefeller Foundation, GlaxoSmithKline, Gilead Sciences, Boehringer-Ingelheim, and Abbott Laboratories.…”

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. by Mugyenyi, P, Walker, A, Hakim, J, Munderi, P, Gibb, D, Kityo, C, Reid, A, Grosskurth, H, Darbyshire, J, Ssali, F, Bray, D, Katabira, E, Babiker, A, Gilks, C, Grosskurth, H, Munderi, P, Kabuye, G, Nsibambi, D, Kasirye, R, Zalwango, E, Nakazibwe, M, Kikaire, B, Nassuna, G, Massa, R, Fadhiru, K

“…FUNDING: UK Medical Research Council, the UK Department for International Development, the Rockefeller Foundation, GlaxoSmithKline, Gilead Sciences, Boehringer-Ingelheim, and Abbott Laboratories.…”